Dissecting mechanisms of sensitivity to B7-H3 (CD276)-targeted therapeutics in prostate cancer (PC)

Project: Research project

Project Details

Description

Dissecting mechanisms of sensitivity to B7-H3 (CD276)-targeted therapeutics in prostate cancer (PC)
StatusActive
Effective start/end date4/1/243/31/29

Funding

  • NIH NATIONAL CANCER INSTITUTE (NCI)

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.